Neurological Biomarkers Market - Global Outlook and Forecast 2021-2027
Report Code: KNJ776997 No. of Pages: 104 Category: Pharmaceuticals and Healthcare
Publisher: Date of Publish:
Publisher: Date of Publish:
This report contains market size and forecasts of Neurological Biomarkers in global, including the following market information:
Global Neurological Biomarkers Market Revenue, 2016-2021, 2022-2027, ($ millions)
Global Neurological Biomarkers Market Sales, 2016-2021, 2022-2027, (K Units)
Global top five Neurological Biomarkers companies in 2020 (%)
The global Neurological Biomarkers market was valued at 6478.4 million in 2020 and is projected to reach US$ 9207.7 million by 2027, at a CAGR of 9.2% during the forecast period.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Neurological Biomarkers manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Neurological Biomarkers Market, By Type, 2016-2021, 2022-2027 ($ Millions) & (K Units)
Global Neurological Biomarkers Market Segment Percentages, By Type, 2020 (%)
Proteomics
Genomics
Imaging
Bioinformatics
Others
Global Neurological Biomarkers Market, By Application, 2016-2021, 2022-2027 ($ Millions) & (K Units)
Global Neurological Biomarkers Market Segment Percentages, By Application, 2020 (%)
Diagnostics
Drug Discovery
Personalized Medicine
Others
Global Neurological Biomarkers Market, By Region and Country, 2016-2021, 2022-2027 ($ Millions) & (K Units)
Global Neurological Biomarkers Market Segment Percentages, By Region and Country, 2020 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Neurological Biomarkers revenues in global market, 2016-2021 (Estimated), ($ millions)
Key companies Neurological Biomarkers revenues share in global market, 2020 (%)
Key companies Neurological Biomarkers sales in global market, 2016-2021 (Estimated), (K Units)
Key companies Neurological Biomarkers sales share in global market, 2020 (%)
Further, the report presents profiles of competitors in the market, key players include:
Thermo Fisher Scientific
Merck
Quest Diagnostics
Abbott
Roche
Illumina
Bio-Rad Laboratories
QIAGEN
Myriad RBM
Cisbio Bioassays
Athena Diagnostics
BGI
Wuxi APP
Aepodia
Proteome Sciences
Genewiz
1 Introduction to Research & Analysis Reports
1.1 Neurological Biomarkers Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Neurological Biomarkers Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Neurological Biomarkers Overall Market Size
2.1 Global Neurological Biomarkers Market Size: 2021 VS 2027
2.2 Global Neurological Biomarkers Revenue, Prospects & Forecasts: 2016-2027
2.3 Global Neurological Biomarkers Sales (Consumption): 2016-2027
3 Company Landscape
3.1 Top Neurological Biomarkers Players in Global Market
3.2 Top Global Neurological Biomarkers Companies Ranked by Revenue
3.3 Global Neurological Biomarkers Revenue by Companies
3.4 Global Neurological Biomarkers Sales by Companies
3.5 Global Neurological Biomarkers Price by Manufacturer (2016-2021)
3.6 Top 3 and Top 5 Neurological Biomarkers Companies in Global Market, by Revenue in 2020
3.7 Global Manufacturers Neurological Biomarkers Product Type
3.8 Tier 1, Tier 2 and Tier 3 Neurological Biomarkers Players in Global Market
3.8.1 List of Global Tier 1 Neurological Biomarkers Companies
3.8.2 List of Global Tier 2 and Tier 3 Neurological Biomarkers Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Neurological Biomarkers Market Size Markets, 2021 & 2027
4.1.2 Proteomics
4.1.3 Genomics
4.1.4 Imaging
4.1.5 Bioinformatics
4.1.6 Others
4.2 By Type - Global Neurological Biomarkers Revenue & Forecasts
4.2.1 By Type - Global Neurological Biomarkers Revenue, 2016-2021
4.2.2 By Type - Global Neurological Biomarkers Revenue, 2022-2027
4.2.3 By Type - Global Neurological Biomarkers Revenue Market Share, 2016-2027
4.3 By Type - Global Neurological Biomarkers Sales & Forecasts
4.3.1 By Type - Global Neurological Biomarkers Sales, 2016-2021
4.3.2 By Type - Global Neurological Biomarkers Sales, 2022-2027
4.3.3 By Type - Global Neurological Biomarkers Sales Market Share, 2016-2027
4.4 By Type - Global Neurological Biomarkers Price (Manufacturers Selling Prices), 2016-2027
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Neurological Biomarkers Market Size, 2021 & 2027
5.1.2 Diagnostics
5.1.3 Drug Discovery
5.1.4 Personalized Medicine
5.1.5 Others
5.2 By Application - Global Neurological Biomarkers Revenue & Forecasts
5.2.1 By Application - Global Neurological Biomarkers Revenue, 2016-2021
5.2.2 By Application - Global Neurological Biomarkers Revenue, 2022-2027
5.2.3 By Application - Global Neurological Biomarkers Revenue Market Share, 2016-2027
5.3 By Application - Global Neurological Biomarkers Sales & Forecasts
5.3.1 By Application - Global Neurological Biomarkers Sales, 2016-2021
5.3.2 By Application - Global Neurological Biomarkers Sales, 2022-2027
5.3.3 By Application - Global Neurological Biomarkers Sales Market Share, 2016-2027
5.4 By Application - Global Neurological Biomarkers Price (Manufacturers Selling Prices), 2016-2027
6 Sights by Region
6.1 By Region - Global Neurological Biomarkers Market Size, 2021 & 2027
6.2 By Region - Global Neurological Biomarkers Revenue & Forecasts
6.2.1 By Region - Global Neurological Biomarkers Revenue, 2016-2021
6.2.2 By Region - Global Neurological Biomarkers Revenue, 2022-2027
6.2.3 By Region - Global Neurological Biomarkers Revenue Market Share, 2016-2027
6.3 By Region - Global Neurological Biomarkers Sales & Forecasts
6.3.1 By Region - Global Neurological Biomarkers Sales, 2016-2021
6.3.2 By Region - Global Neurological Biomarkers Sales, 2022-2027
6.3.3 By Region - Global Neurological Biomarkers Sales Market Share, 2016-2027
6.4 North America
6.4.1 By Country - North America Neurological Biomarkers Revenue, 2016-2027
6.4.2 By Country - North America Neurological Biomarkers Sales, 2016-2027
6.4.3 US Neurological Biomarkers Market Size, 2016-2027
6.4.4 Canada Neurological Biomarkers Market Size, 2016-2027
6.4.5 Mexico Neurological Biomarkers Market Size, 2016-2027
6.5 Europe
6.5.1 By Country - Europe Neurological Biomarkers Revenue, 2016-2027
6.5.2 By Country - Europe Neurological Biomarkers Sales, 2016-2027
6.5.3 Germany Neurological Biomarkers Market Size, 2016-2027
6.5.4 France Neurological Biomarkers Market Size, 2016-2027
6.5.5 U.K. Neurological Biomarkers Market Size, 2016-2027
6.5.6 Italy Neurological Biomarkers Market Size, 2016-2027
6.5.7 Russia Neurological Biomarkers Market Size, 2016-2027
6.5.8 Nordic Countries Neurological Biomarkers Market Size, 2016-2027
6.5.9 Benelux Neurological Biomarkers Market Size, 2016-2027
6.6 Asia
6.6.1 By Region - Asia Neurological Biomarkers Revenue, 2016-2027
6.6.2 By Region - Asia Neurological Biomarkers Sales, 2016-2027
6.6.3 China Neurological Biomarkers Market Size, 2016-2027
6.6.4 Japan Neurological Biomarkers Market Size, 2016-2027
6.6.5 South Korea Neurological Biomarkers Market Size, 2016-2027
6.6.6 Southeast Asia Neurological Biomarkers Market Size, 2016-2027
6.6.7 India Neurological Biomarkers Market Size, 2016-2027
6.7 South America
6.7.1 By Country - South America Neurological Biomarkers Revenue, 2016-2027
6.7.2 By Country - South America Neurological Biomarkers Sales, 2016-2027
6.7.3 Brazil Neurological Biomarkers Market Size, 2016-2027
6.7.4 Argentina Neurological Biomarkers Market Size, 2016-2027
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Neurological Biomarkers Revenue, 2016-2027
6.8.2 By Country - Middle East & Africa Neurological Biomarkers Sales, 2016-2027
6.8.3 Turkey Neurological Biomarkers Market Size, 2016-2027
6.8.4 Israel Neurological Biomarkers Market Size, 2016-2027
6.8.5 Saudi Arabia Neurological Biomarkers Market Size, 2016-2027
6.8.6 UAE Neurological Biomarkers Market Size, 2016-2027
7 Manufacturers & Brands Profiles
7.1 Thermo Fisher Scientific
7.1.1 Thermo Fisher Scientific Corporate Summary
7.1.2 Thermo Fisher Scientific Business Overview
7.1.3 Thermo Fisher Scientific Neurological Biomarkers Major Product Offerings
7.1.4 Thermo Fisher Scientific Neurological Biomarkers Sales and Revenue in Global (2016-2021)
7.1.5 Thermo Fisher Scientific Key News
7.2 Merck
7.2.1 Merck Corporate Summary
7.2.2 Merck Business Overview
7.2.3 Merck Neurological Biomarkers Major Product Offerings
7.2.4 Merck Neurological Biomarkers Sales and Revenue in Global (2016-2021)
7.2.5 Merck Key News
7.3 Quest Diagnostics
7.3.1 Quest Diagnostics Corporate Summary
7.3.2 Quest Diagnostics Business Overview
7.3.3 Quest Diagnostics Neurological Biomarkers Major Product Offerings
7.3.4 Quest Diagnostics Neurological Biomarkers Sales and Revenue in Global (2016-2021)
7.3.5 Quest Diagnostics Key News
7.4 Abbott
7.4.1 Abbott Corporate Summary
7.4.2 Abbott Business Overview
7.4.3 Abbott Neurological Biomarkers Major Product Offerings
7.4.4 Abbott Neurological Biomarkers Sales and Revenue in Global (2016-2021)
7.4.5 Abbott Key News
7.5 Roche
7.5.1 Roche Corporate Summary
7.5.2 Roche Business Overview
7.5.3 Roche Neurological Biomarkers Major Product Offerings
7.5.4 Roche Neurological Biomarkers Sales and Revenue in Global (2016-2021)
7.5.5 Roche Key News
7.6 Illumina
7.6.1 Illumina Corporate Summary
7.6.2 Illumina Business Overview
7.6.3 Illumina Neurological Biomarkers Major Product Offerings
7.6.4 Illumina Neurological Biomarkers Sales and Revenue in Global (2016-2021)
7.6.5 Illumina Key News
7.7 Bio-Rad Laboratories
7.7.1 Bio-Rad Laboratories Corporate Summary
7.7.2 Bio-Rad Laboratories Business Overview
7.7.3 Bio-Rad Laboratories Neurological Biomarkers Major Product Offerings
7.4.4 Bio-Rad Laboratories Neurological Biomarkers Sales and Revenue in Global (2016-2021)
7.7.5 Bio-Rad Laboratories Key News
7.8 QIAGEN
7.8.1 QIAGEN Corporate Summary
7.8.2 QIAGEN Business Overview
7.8.3 QIAGEN Neurological Biomarkers Major Product Offerings
7.8.4 QIAGEN Neurological Biomarkers Sales and Revenue in Global (2016-2021)
7.8.5 QIAGEN Key News
7.9 Myriad RBM
7.9.1 Myriad RBM Corporate Summary
7.9.2 Myriad RBM Business Overview
7.9.3 Myriad RBM Neurological Biomarkers Major Product Offerings
7.9.4 Myriad RBM Neurological Biomarkers Sales and Revenue in Global (2016-2021)
7.9.5 Myriad RBM Key News
7.10 Cisbio Bioassays
7.10.1 Cisbio Bioassays Corporate Summary
7.10.2 Cisbio Bioassays Business Overview
7.10.3 Cisbio Bioassays Neurological Biomarkers Major Product Offerings
7.10.4 Cisbio Bioassays Neurological Biomarkers Sales and Revenue in Global (2016-2021)
7.10.5 Cisbio Bioassays Key News
7.11 Athena Diagnostics
7.11.1 Athena Diagnostics Corporate Summary
7.11.2 Athena Diagnostics Neurological Biomarkers Business Overview
7.11.3 Athena Diagnostics Neurological Biomarkers Major Product Offerings
7.11.4 Athena Diagnostics Neurological Biomarkers Sales and Revenue in Global (2016-2021)
7.11.5 Athena Diagnostics Key News
7.12 BGI
7.12.1 BGI Corporate Summary
7.12.2 BGI Neurological Biomarkers Business Overview
7.12.3 BGI Neurological Biomarkers Major Product Offerings
7.12.4 BGI Neurological Biomarkers Sales and Revenue in Global (2016-2021)
7.12.5 BGI Key News
7.13 Wuxi APP
7.13.1 Wuxi APP Corporate Summary
7.13.2 Wuxi APP Neurological Biomarkers Business Overview
7.13.3 Wuxi APP Neurological Biomarkers Major Product Offerings
7.13.4 Wuxi APP Neurological Biomarkers Sales and Revenue in Global (2016-2021)
7.13.5 Wuxi APP Key News
7.14 Aepodia
7.14.1 Aepodia Corporate Summary
7.14.2 Aepodia Business Overview
7.14.3 Aepodia Neurological Biomarkers Major Product Offerings
7.14.4 Aepodia Neurological Biomarkers Sales and Revenue in Global (2016-2021)
7.14.5 Aepodia Key News
7.15 Proteome Sciences
7.15.1 Proteome Sciences Corporate Summary
7.15.2 Proteome Sciences Business Overview
7.15.3 Proteome Sciences Neurological Biomarkers Major Product Offerings
7.15.4 Proteome Sciences Neurological Biomarkers Sales and Revenue in Global (2016-2021)
7.15.5 Proteome Sciences Key News
7.16 Genewiz
7.16.1 Genewiz Corporate Summary
7.16.2 Genewiz Business Overview
7.16.3 Genewiz Neurological Biomarkers Major Product Offerings
7.16.4 Genewiz Neurological Biomarkers Sales and Revenue in Global (2016-2021)
7.16.5 Genewiz Key News
8 Global Neurological Biomarkers Production Capacity, Analysis
8.1 Global Neurological Biomarkers Production Capacity, 2016-2027
8.2 Neurological Biomarkers Production Capacity of Key Manufacturers in Global Market
8.3 Global Neurological Biomarkers Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Neurological Biomarkers Supply Chain Analysis
10.1 Neurological Biomarkers Industry Value Chain
10.2 Neurological Biomarkers Upstream Market
10.3 Neurological Biomarkers Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Neurological Biomarkers Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
NEED Help?
If you need any help or guidance, please feel free to call us.
USA : +1 (661) 636 6162
INDIA : +91 9325802062
or
Write us on : sales@kandjmarketresearch.com